These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5693 related articles for article (PubMed ID: 3789758)
1. [Restoration of immunologic responsiveness by PSK in tumor-bearing animals]. Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K Gan To Kagaku Ryoho; 1986 Dec; 13(12):3468-75. PubMed ID: 3789758 [TBL] [Abstract][Full Text] [Related]
2. [Restoration of depressed immune responses by PSK in C3H/He mice bearing the syngeneic X5563 tumor]. Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K Gan To Kagaku Ryoho; 1986 Dec; 13(12):3453-60. PubMed ID: 3789756 [TBL] [Abstract][Full Text] [Related]
3. Competitive action of a biological response modifier, PSK, on a humoral immunosuppressive factor produced in tumor-bearing hosts. Matsunaga K; Morita I; Iijima H; Endo H; Oguchi Y; Yoshimura M; Fujii T; Yoshikumi C; Nomoto K J Clin Lab Immunol; 1990 Mar; 31(3):127-36. PubMed ID: 1966997 [TBL] [Abstract][Full Text] [Related]
4. [Competitive effect of PSK against the immunosuppressive effect induced in the sera of mice bearing syngeneic tumors]. Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K Gan To Kagaku Ryoho; 1986 Dec; 13(12):3461-7. PubMed ID: 3789757 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of effector cell activities in mice bearing syngeneic plasmacytoma X5563 by a biological response modifier, PSK. Matsunaga K; Iijima H; Aota M; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K J Clin Lab Immunol; 1992 Jan; 37(1):21-37. PubMed ID: 1339233 [TBL] [Abstract][Full Text] [Related]
6. Restoration of immune responsiveness by a biological response modifier, PSK, in aged mice bearing syngeneic transplantable tumor. Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K J Clin Lab Immunol; 1987 Nov; 24(3):143-9. PubMed ID: 3430562 [TBL] [Abstract][Full Text] [Related]
7. The effect of a biological response modifier, PSK, on the intestinal immune system in tumor-bearing mice. Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K Anticancer Res; 1987; 7(3 Pt B):509-12. PubMed ID: 3631910 [TBL] [Abstract][Full Text] [Related]
8. Effect of PSK on prohibited immunity of splenectomized mice. Fujii T; Kano T; Saito K; Kobayashi Y; Iijima H; Matsumoto T; Yoshikumi C; Taguchi T Anticancer Res; 1987; 7(4B):845-8. PubMed ID: 3674771 [TBL] [Abstract][Full Text] [Related]
9. Neonatal inoculation with the protein-bound polysaccharide PSK increases resistance of adult animals to challenge with syngeneic tumor cells and reduces azoxymethane-induced precancerous lesions in the colon. Matsunaga K; Iijima H; Kobayashi H Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1313-22. PubMed ID: 11142416 [TBL] [Abstract][Full Text] [Related]
10. Effect of PSK on cytotoxicity against sarcoma-180 in tumor-bearing mice. Oguchi Y; Ando T; Matsunaga K; Fujii T; Yoshikumi C; Nomoto K Anticancer Res; 1987; 7(4B):681-4. PubMed ID: 3499859 [TBL] [Abstract][Full Text] [Related]
11. Suppression of hepatic natural killer activity by liver metastasis of cancer and restoration of killer activity by oral administration of a Basidomycetes-derived polysaccharide, PSK. Suo J; Tanaka N; Hizuta A; Yunoki S; Orita K Acta Med Okayama; 1994 Oct; 48(5):237-42. PubMed ID: 7863794 [TBL] [Abstract][Full Text] [Related]
12. [Effect of PSK on the recovery of macrophage function in tumor-bearing mice]. Ando T; Mastuda Y; Matsunaga K; Fujii T; Yoshikumi C; Nomoto K Gan To Kagaku Ryoho; 1984 Apr; 11(4):827-34. PubMed ID: 6721504 [TBL] [Abstract][Full Text] [Related]
13. Effect of Krestin (PSK) on the induction of IL-2 activated killer cells. Sakamaki S; Kohgo Y; Nojiri S; Kanisawa Y; Ito Y; Takahashi M; Ueno Y; Hirayama Y; Niitsu Y Jpn J Clin Oncol; 1992 Apr; 22(2):79-83. PubMed ID: 1619782 [TBL] [Abstract][Full Text] [Related]
14. Effects of biological response modifiers with different modes of action used separately and together on immune responses in mice with syngeneic tumours. Matsunaga K; Morita I; Iijima H; Endoh H; Oguchi Y; Yoshimura M; Fujii T; Yoshikumi C; Nomoto K J Int Med Res; 1992 Sep; 20(5):406-21. PubMed ID: 1280606 [TBL] [Abstract][Full Text] [Related]
15. Effects of PSK, an antitumor protein-bound polysaccharide, on the surface charge of lymphocytes in X5563-bearing mice. Hayashi H; Fujii T; Fujii M; Yoshikumi C; Kawai Y; Shimizu M; Iwaguchi T J Clin Lab Immunol; 1987 Sep; 24(1):33-7. PubMed ID: 3681950 [TBL] [Abstract][Full Text] [Related]
16. Tumor growth promoting activity of an immunosuppressive substance and its modulation by protein-bound polysaccharide PSK. Fujii M; Fujii T; Saito K; Takahashi N; Yoshikumi C; Kakuchi J; Kawai Y Immunol Lett; 1987 Aug; 15(4):347-51. PubMed ID: 3692538 [TBL] [Abstract][Full Text] [Related]
17. Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones. Algarra I; Collado A; Garrido F J Exp Clin Cancer Res; 1997 Dec; 16(4):373-80. PubMed ID: 9505208 [TBL] [Abstract][Full Text] [Related]
18. [Effect of PSK on the recovery of macrophage function and T cell-mediated immunity in tumor-bearing mice]. Tsuru S; Taniguchi M; Zinnaka Y; Nomoto K Gan To Kagaku Ryoho; 1984 Nov; 11(11):2375-80. PubMed ID: 6333849 [TBL] [Abstract][Full Text] [Related]
19. [Effect of PSK on DMH (dimethyl hydrazine) induction of cancer]. Sakita M; Imai H; Yamane T; Kasuga M; Torii T; Kageyama N; Fujita Y; Majima S Gan To Kagaku Ryoho; 1982 Jul; 9(7):1216-25. PubMed ID: 7184451 [TBL] [Abstract][Full Text] [Related]
20. Involution of the thymus in tumor-bearing mice and its restoration by PSK. II. Mechanism of the involution and its restoration. Oguchi Y; Morita I; Fujii T; Matsunaga K; Yoshikumi C; Kawai Y; Tsuru S; Nomoto K J Clin Lab Immunol; 1987 Oct; 24(2):93-9. PubMed ID: 3437442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]